GO
Loading...

Enter multiple symbols separated by commas

Market Outlook

More

  • Will Dovish Fed tiptoe into tapering? Wednesday, 18 Sep 2013 | 11:47 AM ET

    The Fed is expected to take the historic but small step of slowing its easing programs and gradually steer markets toward more normal interest rates.

  • European stocks trim gains but close higher Wednesday, 18 Sep 2013 | 11:31 AM ET
    European stocks trim gains but close higher

    The SEC has approved the CEO pay ratio disclosure plan by a vote of 3 to 2, reports CNBC's Mary Thompson. And a check on all the market moving events from Europe today, with CNBC's Simon Hobbs.

  • Sovereign debt crisis creates some 'downside' vulnerability: Expert

    Dino Kos, CLS Bank, and Barry Knapp, Barclays, discuss how the nation's budget deficit and the Fed's tapering decision will likely impact the markets.

  • Markets open for trading Wednesday, 18 Sep 2013 | 9:30 AM ET
    Markets open for trading

    The "Squawk on the Street" crew shares their thoughts on what investors should be watching throughout the trading day.

  • Wednesday's market roadmap Wednesday, 18 Sep 2013 | 9:01 AM ET
    Wednesday's market roadmap

    The "Squawk on the Street" news team reports on today's top business headlines, including Apple's new operating system; FedEx's strong earnings, and Starbuck's stand on the "open carry" gun policy.

  • Cramer's stocks to watch: Goldman Sachs Wednesday, 18 Sep 2013 | 8:52 AM ET
    Cramer's stocks to watch: Goldman Sachs

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today, Cramer shares his thoughts on Goldman Sachs.

  • Why the Fed's next move matters Wednesday, 18 Sep 2013 | 8:08 AM ET
    Why the Fed's next move matters

    James Paulsen, Wells Capital Management, and Austan Goolsbee, University of Chicago, discuss the likely outcome of the Fed's tapering decision and the President's pick to head the Federal Reserve.

  • Reading the Fed's tea leaves Wednesday, 18 Sep 2013 | 7:06 AM ET
    Reading the Fed's tea leaves

    CNBC's Steve Liesman provides a preview of the Fed's decision on interest rates and possible tapering program. And Gary Stern, former Minneapolis Fed president, shares his thoughts on Fed policy and the looming budget debate on Capitol Hill.

  • Barometers of global business: Hotels & electric Wednesday, 18 Sep 2013 | 6:45 AM ET
    Barometers of global business: Hotels & electric

    Vasant Prabhu, Starwood Hotels & Resorts CFO, and Brian Tierney, American Electric Power CFO, share their thought on how the Fed's tapering policy and health care reform are impacting their businesses.

  • $15 billion taper 'baked in the cake': Expert Wednesday, 18 Sep 2013 | 6:12 AM ET
    $15 billion taper 'baked in the cake': Expert

    Jeff Mortimer, BNY Mellon Wealth Management, and Bill Smead, Smead Capital Management, discuss how the Fed's policy decisions are impacting the markets and the housing recovery.

  • Modest gains ahead of Fed decision Tuesday, 17 Sep 2013 | 7:52 PM ET
    Modest gains ahead of Fed decision

    To break down today's markets and discuss if tapering is already priced in, is Carol Roth, author of "The Entrepreneur Equation," and John Rutledge, Safanad.

  • No Huddle Offense: The importance of renewable energy Tuesday, 17 Sep 2013 | 6:58 PM ET
    No Huddle Offense: The importance of renewable energy

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • BioMarin CEO on making a difference in patients' lives Tuesday, 17 Sep 2013 | 6:45 PM ET
    BioMarin CEO on making a difference in patients' lives

    BioMarin Pharmaceutical is the developer of orphan drugs for ultra-rare genetic disorders. The stock has been red hot and is up 245 percent in the last 3 years. JJ Bienaime, CEO, provides insight into the pharmaceutical company.

  • Biotechs have been on fire: Cramer Tuesday, 17 Sep 2013 | 6:25 PM ET
    Biotechs have been on fire: Cramer

    Mad Money host Jim Cramer looks at 2013's best performing healthcare and biotech stocks including Celgene and Regeneron.

  • Carrizo CEO: 'We are not that bullish on dry gas' Tuesday, 17 Sep 2013 | 6:15 PM ET
    Carrizo CEO: 'We are not that bullish on dry gas'

    Carrizo Oil & Gas is an independent oil producer that has many acres in Texas' Eagle Ford shale, Colorado's Niobrara shale, and Ohio's Utica's shale. With domestic oil stocks soaring, Chip Johnson, president and CEO of Carrizo Oil & Gas, discusses what is driving the stock higher.

  • Don't fear the gauntlet, it will give buying opportunities: Cramer

    Mad Money host Jim Cramer discusses what to think about as the Federal Reserve sets to release a statement on tapering.

  • Today's top moments Tuesday, 17 Sep 2013 | 5:45 PM ET
    Today's top moments

    The "Fast Money" team recaps the major CNBC headlines of the day, including Scott McNealy's, former chairman of Sun Microsystems, comments on charity, Microsoft's boost of dividend and look ahead at what to watch for in tomorrow's trading session.

  • Why I like Microsoft model over Google: ValueAct CEO Tuesday, 17 Sep 2013 | 5:40 PM ET
    Microsoft's $40 billion buy back

    Following Microsoft's announcement of a 22 percent dividend increase. CNBC's Kate Kelly spoke to ValueAct's Jeffrey Ubben about his new seat on the board at Microsoft. And John Netto, M3 Capital president, shares what you should be watching ahead of tomorrow's FOMC statement.

  • Can GM cut Tesla off? Tuesday, 17 Sep 2013 | 5:30 PM ET
    Can GM cut Tesla off?

    General Motors reveals its plans for a long-range electric car. Karen Finerman and Brian Kelly debate whether GM will be able to drive away with a piece of Tesla's market share. Mike Khouw provides the options perspective.

  • Tomorrow In :30 Tuesday, 17 Sep 2013 | 4:53 PM ET
    Tomorrow In :30

    What to watch in tomorrow's trading session, with Chad Morganlander, Stifel; Brad Friedlander, Angel Oak Capital; and Dean Colucci, MLV and Company.